Taking lab-based cancer models to the next level
08.04.2016Researchers from iBET have developed a new method that better mimics disease progression in vitro providing a better tool for drug screening and target validation in pre-clinical oncology.
Researchers from iBET have developed a new method that better mimics disease progression in vitro providing a better tool for drug screening and target validation in pre-clinical oncology.
The Therapeutics4DM project, which brings together a multidisciplinary research team from iBET, ITQB-NOVA, CEDOC, APDP and IMM, was awarded the Nuno Castel Branco/Portuguese Society of Diabetology Fellowship
Quoting Johannes Baillou, “I am impressed with how much you have to offer and how great it is to see this mix between Business and Academia. There are not so many of such examples”.
Check out iBET's most Recent News: Collaborations; Research Highlights; New Projects; Awards and much more